Boviplas Development Registration and C ommercialisation Project - Stage 2
Project start date: | 01 March 2006 |
Project end date: | 14 May 2020 |
Publication date: | 28 April 2020 |
Project status: | Completed |
Livestock species: | Grassfed cattle, Grainfed cattle |
Relevant regions: | National |
Summary
This project aimed to register a quality controlled commercial bovine plasma product that can meet the needs of producers who have valuable cattle that require plasma treatment. In veterinary medicine, plasma is used in both pet and equine industries to medically treat certain diseases and to increase passive immunity; for example, to treat failure of passive transfer (FPT) of immunity when neonatal mammals do not receive colostrum. However, no quality controlled commercial plasma products are registered for use in cattle in Australia. This project has seen the development of a new plasma product for cattle (Boviplas), the first of its kind in Australia.
More information
Contact email: | reports@mla.com.au |
Primary researcher: | Plasvacc Pty Ltd |